CMS Open Payments · Program Year 2024
Mevion_Medical_Systems_Inc
Mevion_Medical_Systems_Inc reported $73,715.38 across General Payments, Research, and Ownership to 71 physicians and teaching hospitals across 72 transactions.
- $73.7K Below-median payer
- All-tracks total
- 72 Below-median volume
- Transactions
- 71 Below-median reach
- Recipients
- +$6.8K
- General Payments vs PY2023
Mevion_Medical_Systems_Inc reported $73,715.38 across all CMS Open Payments tracks (General + Research + Ownership) to 71 physicians and teaching hospitals in Program Year 2024 - ranking #1261 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $31,452.28, averaging $1.0K per recipient.
How Mevion_Medical_Systems_Inc's $73.7K all-tracks total breaks down
Mevion_Medical_Systems_Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
11/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer mevion-medical-systems-inc Mevion_Medical_Systems_Inc
$73.7K · #1261/1,925 · 0.0% industry · PY2024
- TOT $73.7K
- RANK #1261
- SHARE 0.0%
- TXN 72
- RCP 71
- CAT 5
- GEN $31.5K
- ΔGEN +$6.8K
- TOP1 19.6%
- PY 2024
Volume peers
Nearest volume peer: Clariance SAS ($73.8K)
Mevion_Medical_Systems_Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Mevion_Medical_Systems_Inc's CMS-reported General Payments increased by $6.8K (+27.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MEVION_MEDICAL_SYSTEMS_INCPY2023: MEVION_MEDICAL_SYSTEMS_INCPY2024: Mevion_Medical_Systems_Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $24,652.84
- PY2024
- $31,452.28
What the Data Shows for Mevion_Medical_Systems_Inc
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Mevion_Medical_Systems_Inc, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
10 transactions worth $23.3K make "Honoraria" the top general-payment category in the 5-category breakdown below, 74.1% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 5 types of general payments, Mevion_Medical_Systems_Inc's largest category was "Honoraria" at $23.3K - 74.1% of General Payments.
Mevion_Medical_Systems_Inc reports 5 general-payment categories - the top three are Honoraria (74.1%), Food and Beverage (11.4%), and Consulting Fee (9.5%). The remaining 2 categories make up 5.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Mevion_Medical_Systems_Inc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $23.3K | 10 | 74.1% |
| Food and Beverage | $3.6K | 52 | 11.4% |
| Consulting Fee | $3.0K | 1 | 9.5% |
| Travel and Lodging | $1.6K | 7 | 5.0% |
| Gift | $10.00 | 1 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $22,373.37 (71.1%) of $31,452.28 in this company's General Payments records across 33 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Mevion_Medical_Systems_Inc
The five named recipients with the highest reported General Payments from this company
- 1
Nancy J Tarbell Md
$6,170.00 across 3 reported transactions
- 2
Jeffrey D Bradley Md
$5,104.62 across 3 reported transactions
- 3
Billy W Loo Md
$4,939.85 across 6 reported transactions
- 4
Rahul R Parikh Md
$3,158.90 across 2 reported transactions
- 5
Barnes-Jewish Hospital
$3,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Mevion_Medical_Systems_Inc's spend rank (#1261 of 1,925, bottom 35% by spend) and concentration rank (#934 of 1,838, bottom 49% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Astellas Pharma Europe Ltd : $523.2K total payments, HHI 1263
- Coltene Whaledent Inc. : $105.1K total payments, HHI 1261
- Mylan Inc. : $367.4K total payments, HHI 1254
- RGH Enterprises LLC : $7.4K total payments, HHI 1248
- Summit Surgical Corp. : $5.2K total payments, HHI 1241
- Vector Surgical, LLC : $29.7K total payments, HHI 1240
- Mevion_Medical_Systems_Inc (this company) : $31.5K total payments, HHI 1237
- LockedBrands : $852.39 total payments, HHI 1236
- Microaire Surgical Instruments Llc : $121.1K total payments, HHI 1234
- Serpex Medical Inc : $96.3K total payments, HHI 1224
- Chiesi USA, Inc. : $5.4M total payments, HHI 1223
- bioMerieux Inc : $716.8K total payments, HHI 1223
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Mevion_Medical_Systems_Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Mevion_Medical_Systems_Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Mevion_Medical_Systems_Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Omniscient Neurotechnology America Ltd
Lightbody Medical Technologies Inc
KOELIS Inc.
Ascend Therapeutics US, LLC
Aspira Women's Health Inc
Put this to use
Mevion_Medical_Systems_Inc ranks #1261 of 1,925 by all-tracks total payments, led by "Honoraria".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Honoraria" spend across every manufacturer, not just Mevion_Medical_Systems_Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.